Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$72.92 - $99.73 $37,116 - $50,762
509 Added 71.49%
1,221 $89,000
Q2 2022

Aug 15, 2022

BUY
$84.23 - $147.57 $25,016 - $43,828
297 Added 71.57%
712 $67,000
Q1 2022

May 16, 2022

BUY
$122.89 - $171.74 $50,999 - $71,272
415 New
415 $57,000
Q4 2021

Feb 14, 2022

SELL
$156.0 - $265.78 $14,196 - $24,185
-91 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$228.69 - $274.2 $20,810 - $24,952
91 New
91 $24,000
Q2 2021

Aug 16, 2021

SELL
$169.89 - $231.37 $81,377 - $110,826
-479 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$143.93 - $207.3 $61,745 - $88,931
429 Added 858.0%
479 $81,000
Q4 2020

Feb 16, 2021

BUY
$96.1 - $151.18 $4,805 - $7,559
50 New
50 $7,000
Q1 2020

May 15, 2020

SELL
$52.76 - $109.0 $316 - $654
-6 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$69.39 - $97.59 $416 - $585
6 New
6 $1,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.